A carregar...
CHEMOTHERAPY: A new standard combination for recurrent ovarian cancer?
Ovarian cancer that recurs more than 6 months following primary chemotherapy can respond to many different drugs, but retreatment with a combination of carboplatin and paclitaxel has become a standard of care. A combination of pegylated liposomal doxorubicin and carboplatin may provide a slightly bu...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2956193/ https://ncbi.nlm.nih.gov/pubmed/20877420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2010.152 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|